Venous Thromboembolism Treatment Market: Deep Study on Future Insights- 2022-2029

 

The global demand for venous thromboembolism treatment market is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 3.7% CAGR between 2022 and 2029.

More than 3/5th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices and percutaneous thrombectomy devices, collectively account for more than half of the global revenues represented by the venous thromboembolism treatment market.

Get the Sample here: https://www.futuremarketinsights.com/reports/sample/rep-gb-1341

Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and upper pneumatic compression sleeves. Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market.

Poor Reimbursement Scenario Against High Treatment Costs to Restrict Adoption

Several factors are impacting the overall growth of the venous thromboembolism treatment market. The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease. Other factors, such as the increasing retrieval rate of vena cava filters, increasing healthcare awareness, presence of favourable reimbursement policies, and increasing geriatric population, are also responsible for the growth of the venous thromboembolism treatment market.

Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market. The high cost associated with venous thromboembolism treatment therapy, poor reimbursement for some of the treatment devices, and poor insurance support are among the major factors that are expected to hamper the growth of the venous thromboembolism treatment market.

Drug-based Treatment Witnessing Traction across Europe

Although increasing preference for drug-based venous thromboembolism treatment is highly likely to hinder the growth of the market, new-generation drugs, including non-Vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban, are estimated to boost the adoption rate of venous thromboembolism treatment due to increased efficacy. However, there are regional variations to this trend.

North America is expected to be a prominent region in the global venous thromboembolism treatment market because of the presence of a well-developed healthcare infrastructure and numerous technological advancements in the region. The increasing prevalence of venous thromboembolism is also responsible for the boosting the growth of the North America market. Treatment using mechanical and interventional prophylaxis systems is expected to be increasingly adopted in the North American region during the forecast period. In addition, drug-based treatment is expected to gain popularity in the European region, which is expected to subsequently decrease the usage of mechanical and interventional treatments in the region.

On the other hand, increasing per capita healthcare expenditure is one of the macroeconomic factors that is likely to boost the market. Nowadays, certain changes in the socio-economic scenario can also lead to significant growth in the venous thromboembolism treatment market.

Tier 1 Players Account for Nearly 35% Market Revenue Share

Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the venous thromboembolism treatment market are focusing on collaborations and acquisitions. For example, venous thromboembolism treatment is majorly adopted by hospitals, catheterisation laboratories, and ambulatory surgical centres. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.

The report tracks some of the key companies operating in the venous thromboembolism treatment market such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp.  There are several other companies operating in the venous thromboembolism treatment market. AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share in the venous thromboembolism treatment market. These tier 1 companies hold a share of approximately 35% in the venous thromboembolism treatment market.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Dairy Flavored Milk Market: Worldwide Industry Analysis of Key Findings, and New Market Opportunities Explored by 2022-2032

  Dairy Flavored milk  is a product manufactured by mixing milk, sugar or sweetener, coloring, and natural or artificial flavor. Flavored milk offers some essential nutrients like calcium, potassium, vitamins, phosphorus, and protein. Flavored milk is among the healthiest products from the food and beverage industry. Its health benefit is a boost for the market as consumers are moving towards healthy lifestyles. Also, the high shelf life and increase in demand for refrigerated milk products fuel the growth of the flavored milk market globally. The worldwide flavored milk market is supposed to arrive at a valuation of US$ 3,300 Million of every 2022. Generally speaking, deals of flavored milk are projected to develop at a strong CAGR of 6.4% somewhere in the range of 2022 and 2032, adding up to around US$ 6,119.3 Million toward the finish of 2032 The global dairy flavored milk industry is still on the rise as consumption is still low compared to other drinks like carbonated soft dri
Read more

Peanut Butter Market 2022: Increasing Demand for Efficient Management Practices, Key Segment & Opportunities Report-2030

Peanut butter is a low-calorie product with high protein content prepared from grinding of dry roasted peanuts. It serves as a substitute for the dairy butter. Peanut butter can be used as toppings for food products like bread, crackers, and many others. Peanut butter finds application in several end-user sectors such as bakery, savory and sauces, smoothies, and many more. Peanut butter is a rich source of energy that can be used as an alternative to milk butter. Aside the energy derived from the consumption, peanut butter is also a good source of protein, fiber, unsaturated fat and minerals such as magnesium, zinc, potassium, and vitamin E. With these nutritional value obtained from the consumption of peanut butter, the global market is slated to witness robust growth over the forecast period. Moreover, the growing population size of consumers with weight diseases and increasing disposable income of consumers in developed and developing countries are major factors expected to p
Read more

Global Vegan Fast Food Market Current and Future Trends, Growth Insights, Industry Segments and Regional Forecast by 2033

 The global vegan fast food market is predicted to be worth US$ 18829.5 million in 2023 and US$ 27980.2 million by 2033 The global vegan fast food market is predicted to develop due to increased knowledge about the benefits of a vegan diet. An additional factor, such as growing awareness of animal health and cruelty in the food industry, has encouraged individuals to transition from animal-based to plant-based fast food, which has contributed to the market's growth. As a result of these reasons, demand for vegan fast food is expected to rise at a constant 4.5% CAGR, with the United Kingdom, the United States, Germany, and Japan emerging as important manufacturers. Download Comprehensive Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16198 The rise in awareness of health issues and human well-being, as well as changes in lifestyle, are the factors driving the growth of the global vegan fast food market. People are migrating toward vegetarian food
Read more